Effect of felbamate and its combinations with conventional antiepileptics in amygdala-kindled rats

Pharmacology Biochemistry and Behavior

Volumn 78, Issue 1, 2004, Pages 103-110

  Borowicz, K K ^a   Ratnaraj, N ^b   Patsalos, P N ^b   Czuczwar, S J ^a,c  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c INSTITUTE OF AGRICULTURAL MEDICINE   (Poland)

Author keywords

Amygdala kindled seizures; Carbamazepine; Clonazepam; Drug interaction; Felbamate; Phenobarbital; Phenytoin

Indexed keywords

CARBAMAZEPINE; CLONAZEPAM; FELBAMATE; PHENOBARBITAL; PHENYTOIN;

AFTERDISCHARGE; AMYGDALOID NUCLEUS; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTICONVULSANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG BLOOD LEVEL; DRUG BRAIN LEVEL; DRUG EFFECT; FOCAL EPILEPSY; KINDLING; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RATING SCALE; SEIZURE THRESHOLD;

EID: 2442712378     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2004.02.014     Document Type: Article

References (36)

1. Adusumalli V.E., Yang J.T., Wong K.K., Kucharczyk N., Sofia R.D. Felbamate pharmacokinetics in the rat, rabbit, and dog. Drug Metab. Dispos. 19:1991;1116-1119
2. Arroyo S., de la Morena A. Life-threatening adverse events of antiepileptic drugs. Epilepsy Res. 47:2001;155-174
3. Boissier J.R., Tardy J., Diverres J.C. Une nouvelle methode simple pour explorer l'action'tranquilisante: le test de la cheminee. Med. Exp. (Basel). 3:1960;81-84
4. Borowicz K.K., Stasiuk G., Teter J., Kleinrok Z., Gasior M., Czuczwar S.J. Low propensity of conventional antiepileptic drugs for interaction with felbamate against maximal electroshock-induced seizures in mice. J. Neural Transm. 107:2000;733-743
5. Borowicz K.K., Luszczki J.J., Duda A.M., Czuczwar S.J. Effect of topiramate on the anticonvulsant activity of conventional antiepileptic drugs in two models of experimental epilepsy. Epilepsia. 44:2003;640-646
6. Correadetti R., Pugliese A.M. Electrophysiological effects of felbamate. Life Sci. 63:1998;1075-1088
7. Cuadrado A., Amat G., Armijo J.A. Is the interaction between felbamate and valproate against seizures induced by 4-aminopyridine and pentylenetetrazole in mice beneficial? Pharmacol. Res. 48:2003;183-192
8. Cuadrado A., Bravo J., Armijo J.A. Synergistic interaction between felbamate and lamotrigine against seizures induced by 4-aminopyridine and pentylenetetrazole in mice. Eur. J. Pharmacol. 465:2003;43-52
9. Czuczwar S.J., Borowicz K.K. Polytherapy in epilepsy: the experimental evidence. Epilepsy Res. 52:2002;15-23
10. Czuczwar S.J., Turski W.A., Kleinrok Z. Interactions and excitatory amino acid antagonists with conventional antiepileptic drugs. Metab. Brain Dis. 11:1996;143-152
11. Deckers C.L.P., Czuczwar S.J., Hekster Y.A., Keyser A., Kubova H., Meinardi H., et al. Selection of antiepileptic drug polytherapy based on mechanisms of action: the evidence reviewed. Epilepsia. 41:2000;1364-1374
12. DeSarro G., Ongini E., Bertorelli R., Aguglia U., DeSarro A. Excitatory amino acid neurotransmission through both NMDA and non-NMDA receptors is involved in the anticonvulsant activity of felbamate in DBA/2 mice. Eur. J. Pharmacol. 262:1994;11-17
13. Domenici M.R., Marinelli S., Sagratella S. Effects of felbamate, kynurenic acid derivatives and NMDA anatagonists on in vitro kainate-induced epileptiform activity. Life Sci. 58:1996;391-396
14. Ebert U., Löscher W. Characterization of phenytoin-resistant kindled rats, a new model of drug-resistant partial epilepsy: influence of genetic factors. Epilepsy Res. 33:1999;217-226
15. Ebert U., Reissmüller E., Löscher W. The new antiepileptic drugs lamotrigine and felbamate are effective in phenytoin-resistant kindled rats. Neuropharmacology. 39:2000;1893-1903
16. Frey H.-H., Bartels I. Felbamate and meprobamate: a comparison of their anticonvulsant properties. Epilepsy Res. 27:1997;151-164
17. Gordon R., Gels M., Wichmann J., Diamantis W., Sofia R.D. Interaction of felbamate with several other antiepileptic drugs against seizures induced by maximal electroshock in mice. Epilepsia. 34:1993;364-371
18. Hachad H., Raueneau-Majlessi I., Levy R.H. New antiepileptic drugs: review on drug interactions. Ther. Drug Monit. 24:2002;91-103
19. Harty T.P., Rogawski M.A. Felbamate block of recombinant N-methyl-D-aspartate receptors: selectivity for the NR2B subunit. Epilepsy Res. 39:2000;47-55
20. Hunter J.C., Gogas K.R., Hedley L.R., Jacobson L.O., Kassotakis L., Thompson J., et al. The effect of novel anti-epileptic drugs in rat experimental models of acute and chronic pain. Eur. J. Pharmacol. 324:1997;153-160
21. Karunanayake E.H., Joice P.D., Peiris J.B., Meijer J.W., Meinardi H. Serum protein binding of antiepileptic drugs. Ceylon Med. J. 35:1990;25-28
22. Löscher W., Jäckel R., Czuczwar S.J. Is amygdala-kindling in rats a model of drug-resistant partial epilepsy? Exp. Neurol. 93:1989;211-226
23. McNamara J.O. Kindling: an animal model of complex partial epilepsy. Ann. Neurol. 16:1984;S72-S76
24. Mellick G.A. Hemifacial spasm: successful treatment with felbamate. J. Pain Sympt. Manag. 10:1995;392-395
25. Patsalos P.N., Perucca E. Clinically important interactions in epilepsy: general features and interactions between antiepileptic drugs. Lancet Neurol. 6:2003;347-356
26. Patsalos P.N., Perucca E. Clinically important interactions in epilepsy: interactions between antiepileptic drugs and other drugs. Lancet Neurol. 2:2003;473-481
27. Paxinos G., Watson C. The rat brain in stereotaxic coordinates. 2nd ed. 1986;Academic Press, San Diego
28. Pellock J.M. Felbamate in epilepsy therapy: evaluating the risk. Drug Safety. 21:1999;225-239
29. Racine R.J. Modification of seizure activity by electrical stimulation: II. Motor seizure. Electroencephalogr. Clin. Neurophysiol. 32:1972;281-294
30. Rambeck B., Specht U., Wolf P. Pharmacokinetic interactions of the new antiepileptic drugs. Clin. Pharmacokinet. 31:1996;309-324
31. Rho J.M., Donevan S.D., Rogawski M.A. Mechanism of action of the anticonvulsant felbamate: opposing effects on N-methyl-D-aspartate and γ-amino-butyric acid A receptors. Ann. Neurol. 35:1994;229-236
32. Rogawski M.A. The NMDA receptor, NMDA antagonists and epilepsy therapy. A status report. Drugs. 44:1992;279-292
33. Theodore W.H., Jensen P.K., Kwan R.M.F. Felbamate. Clinical use. Levy R.H., Mattson R.H., Meldrum B.S. Antiepileptic drugs. 4th ed. 1995;817-822 Raven Press, New York
34. Venault P., Chapouthier G., De L., Carvalho P., Simiand J., Morre M., et al. Benzodiazepines impair and beta-carbolines enhance performance in learning and memory task. Nature. 321:1986;864-866
35. White H.S., Wolf H.H., Swinyard E.A., Skeen G.A., Sofia R.D. A neuropharmacologic evaluation of felbamate as a novel anticonvulsant. Epilepsia. 33:1992;564
36. Winkler S.R., Luer M.S. Antiepileptic drug review: part 2. Surg. Neurol. 49:1998;566-568